UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307C952. A total of 5 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,529,744 | +124.7% | 11,200 | +119.6% | 0.00% | – |
| Q2 2023 | $1,125,825 | -92.0% | 5,100 | -91.9% | 0.00% | -100.0% |
| Q1 2023 | $14,109,480 | -18.4% | 63,000 | +1.3% | 0.01% | -25.0% |
| Q4 2022 | $17,297,198 | +229.2% | 62,200 | +147.8% | 0.01% | +300.0% |
| Q3 2022 | $5,255,000 | +271.6% | 25,100 | +318.3% | 0.00% | +100.0% |
| Q2 2022 | $1,414,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 22,400 | $5,016,704 | 0.02% |
| JANE STREET GROUP, LLC | 63,000 | $14,109,480 | 0.01% |
| SIMPLEX TRADING, LLC | 7,400 | $1,657 | 0.00% |
| JPMORGAN CHASE & CO | 19,200 | $4,300,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |